Quantifying and resolving multiple vector transformants in <it>S. cerevisiae </it>plasmid libraries

od Gray Elizabeth C, Scanlon Thomas C, Griswold Karl E
Izdano 2009-11-01

Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries

od Scanlon, Thomas C, Gray, Elizabeth C, Griswold, Karl E
Izdano 2009

A High-Throughput Screen for Antibiotic Drug Discovery

od Scanlon, Thomas C., Dostal, Sarah M., Griswold, Karl E.
Izdano 2013

The monoclonal myth

od Scanlon, Thomas C, Jewell, Heather L, Gray, Elizabeth C, Griswold, Karl E
Izdano 2010

Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity

od Gill, Avinash, Scanlon, Thomas C., Osipovitch, Daniel C., Madden, Dean R., Griswold, Karl E.
Izdano 2011

Genetically Enhanced Lysozyme Evades a Pathogen Derived Inhibitory Protein

od Dostal, Sarah M., Fang, Yongliang, Guerrette, Jonathan C., Scanlon, Thomas C., Griswold, Karl E.
Izdano u ACS Chem Biol (2015)

Genetically Engineered Alginate Lyase-PEG Conjugates Exhibit Enhanced Catalytic Function and Reduced Immunoreactivity

od Lamppa, John W., Ackerman, Margaret E., Lai, Jennifer I., Scanlon, Thomas C., Griswold, Karl E.
Izdano 2011

Bioengineered Lysozyme Reduces Bacterial Burden and Inflammation in a Murine Model of Mucoid Pseudomonas aeruginosa Lung Infection

od Teneback, Charlotte C., Scanlon, Thomas C., Wargo, Matthew J., Bement, Jenna L., Griswold, Karl E., Leclair, Laurie W.
Izdano 2013

Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections

od Griswold, Karl E, Bement, Jenna L, Teneback, Charlotte C, Scanlon, Thomas C, Wargo, Matthew J, Leclair, Laurie W
Izdano 2014

Enhanced antimicrobial activity of engineered human lysozyme

od Scanlon, Thomas C., Teneback, Charlotte C., Gill, Avinash, Bement, Jenna L., Weiner, Joshua A., Lamppa, John W., Leclair, Laurie W., Griswold, Karl E.
Izdano 2010